Open AccessDirect medical costs for stage-specific breast cancer: a retrospective analysis
Author(s) -
Qais Alefan,
Alaa Saadeh,
Rami J. Yaghan
Publication year - 2020
Publication title -
breast cancer management
Language(s) - English
Resource type - Journals
eISSN - 1758-1931
pISSN - 1758-1923
DOI - 10.2217/bmt-2019-0014
Subject(s) - medicine , retrospective cohort study , breast cancer , stage (stratigraphy) , medical record , medical costs , cohort , total cost , cost analysis , indirect costs , cancer , gynecology , health care , paleontology , business , accounting , engineering , reliability engineering , economics , biology , microeconomics , economic growth
Aim: To analyze the direct medical costs of breast cancer (BC) patients in the north of Jordan. Patients: A cohort of BC patients treated during 2015 at King Abdullah University Hospital. Methods: A retrospective analysis of 119 patients, where all records including age, sex, treatment processes and costs were extracted from the patients’ profiles and examined. Results: The mean age of patients was 50.8 (±10.2) years. The total sample cost was Jordanian dinar 1,393,325 (US$1,963,560). The mean cost per patient from stage I to IV was Jordanian dinar 6696, 9183, 11,970 and 15,073, respectively. Medications were the most expensive resource used. Stage IV had the highest cost and largest number of patients. Conclusion: Direct medical costs associated with BC are considerable. Three-quarters of the cost were devoted to medications.